Key statistics
On Thursday, Hydreight Technologies Inc (NURS:CVE) closed at 3.60, -35.60% below its 52-week high of 5.59, set on Nov 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.70 |
|---|---|
| High | 3.83 |
| Low | 3.53 |
| Bid | 3.55 |
| Offer | 3.80 |
| Previous close | 3.64 |
| Average volume | 152.90k |
|---|---|
| Shares outstanding | 53.38m |
| Free float | 26.98m |
| P/E (TTM) | 380.75 |
| Market cap | 194.64m CAD |
| EPS (TTM) | 0.0096 CAD |
Data delayed at least 15 minutes, as of Feb 12 2026 20:59 GMT.
More ▼
Announcements
- Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
- Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders
- Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
- Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook
- Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
- Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
- Hydreight Reports Corporate Update and Ranks #25 on Deloitte’s 2025 Technology Fast 50™
- Hydreight Announces Annual General Meeting Results
- Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
- Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals
More ▼
